Business · 26/12/2017Updated: 10/17/2026 · 1 min read
FDA Announces Public Comment Period for Blood Establishment Registration and Product Listing
Summary
The Food and Drug Administration is seeking public input on its proposed collection of information related to blood establishment registration and product listing requirements, as outlined in its regulations and Form FDA 2830, in accordance with the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →